why choose us

First received: December 23, 2022

Clinical Trial: Safety and Effect of Intravitreal Injection of a Derivative of Nucleoside Reverse Transcriptase Inhibitor in Subjects With Diabetic Macular Edema

Study Status: Completed

Recruit Status: RECRUITING

Condition: Diabetic Macular Edema

Study Type: INTERVENTIONAL


Official Title: A Non-randomized, Open Label, Safety and Efficacy Study Evaluating a Single Dose of Kamuvudine-8 (K8) for the Treatment of Patients With Diabetic Macular Edema

Brief Summary: This study is designed to assess the safety and initial evidence of efficacy of the novel compound SOM-401 (K8), a derivative of a nucleoside reverse transcriptase inhibitor, in subjects with untreated, clinically significant, diabetic macular edema (DME).

Read more